Angle Share Discussion Threads

[beatme1] 24/4/2024 10:08

Feels like gst did good nees but share price held back and then plzcing next dayBrokers are forwRd selling jhereplacing around 12p

[boris cobaka] 24/4/2024 10:07

Excellent news. Still all about the money but peeps need to understand how the biopharma Co's progress. It's been a journey and there's still many more miles to cover. Exciting times for AGL, and recognition is slowly dawning.

There'll be a few bumps in the road for sure but they're heading in the right direction.
Goa.

[washingmachine] 24/4/2024 10:06

SK exactly
If they miss , which is a imminent release inbound
They will need money
Imo a placing is being worked

[atmysignal] 24/4/2024 10:05

LOL wait until the afternoon, volume is key. Going much higher

[gspanner] 24/4/2024 10:04

And hints of more on the way in the RNS

[zxie] 24/4/2024 10:00

This is ANGLE's second large pharma company agreement of 2024 as we look to drive a significant expansion of the pharma services business.

[zxie] 24/4/2024 09:58

INSP develops technology to generate electricity using thermodynamics. Interesting things will happen in Q2

[g2theary] 24/4/2024 09:55

I hold here all I've done is sold and bought cheaper :) this will move higher today imo :)

[dreamtwister] 24/4/2024 09:55

Its coming good,

[beatme1] 24/4/2024 09:53

Market makers know the traders like geary they buy and sell for 5% and run awayMms now smashing this down and panic sellers will dump

[andrbea] 24/4/2024 09:47

An agreement with such a big name. Considering the low level of the share price yesterday (on a 5-year chart) I would have thought that a 90% rise was more appropriate, and to the point. Such a weak market this, on AIM, for responding to good news....

[beatme1] 24/4/2024 09:42

I see geary has run away again

[sicilian_kan] 24/4/2024 09:31

jelenko, hopefully they will have enough small customers, but I am going to await the financials before increasing my holding, as last year that was not the case. I don't think anyone is suggesting they will not be around. The issue is whether they need to dilute and if so the cost of that to us shareholders in terms of share price and dilution. At the moment, the share price is rightfully on the up. But if we get a revenue warning at any stage, we will see a sharp reversal.

[jelenko] 24/4/2024 09:26

SK,
Very measured comments and of course sensible but I might add that any company no matter who they are survive on cash flow. Tesco etc need shoppers every day but they don't rns the market when every customer goes through the checkout and all these small customers add up. For what it's worth I think they will move through this phase without the need to raise.
I certainly don't see the large japanese Pharma and now AZN working with a firm that may not be around in a couple of years and also I don't think that they would be recruiting at the level they are without knowing if they could pay the ongoing salaries.

[citys2874] 24/4/2024 09:15

16.00 being paid now mms lifting back up once this breaks 17.00 will move up very fast to 19.00+

[g2theary] 24/4/2024 09:14

20p is a dead certain today :)

[g2theary] 24/4/2024 09:08

Nice trade out 1st thing and back in with more shares :)

[sicilian_kan] 24/4/2024 09:07

Agreed, typo corrected.

[bagpuss67] 24/4/2024 09:06

SK. Q2 25...

[citys2874] 24/4/2024 09:03

volume crossed 3 million in the first hour trading .....buys pressure very strong .....expect mms to let go and let it it breakout very soon

[sicilian_kan] 24/4/2024 08:59

Hi Bermuda, yes the RNS is a very, very good one. Great to see an AZ deal too, which we all thought might happen given the Kyra Mumford connection. However I wouldn't be too dismissive about the financial side. Angle has to hit revenue of £6m-£7m this year [tripling 2023 revenues of £2.2m] to avoid yet another revenue warning. This RNS for £150k will not get us over that line and there has only been one other contract worth £250k announced in the past 5.5 months since the last revenue warning. Angle will also need to raise cash later this year as we only have cash into Q2 25 from recollection. So whilst this RNS is fabulous on the science side and whilst it might help generate very significant revenues further down the line, it doesn't solve the immediate revenue / cash problem that Angle has. Hopefully sales have been strong and the results will be very good, however the relative lack of large [in financial terms] contracts this calendar year gives me hesitation. I bought a few this morning, but I'm going to hold out for the results before deciding whether to increase my stake.

[citys2874] 24/4/2024 08:43

in the top 5 leaderboard risers

[wall street trader] 24/4/2024 08:38

Whatever happens today it won't stop this getting back to a quid within five years - have added more now good news is coming through regularly

[citys2874] 24/4/2024 08:37

up 28 percent very strong buying pressure today ....big pharma ...Fabulous News today